Treasury Chief Rachel Reeves Intends Focused Action on Bills in Upcoming Budget

Chancellor Reeves has stated she is planning "specific measures to deal with cost of living issues" in the upcoming financial statement.

Speaking to media outlets, she noted that reducing inflation is a joint responsibility of both the administration and the Bank of England.

The UK's price growth is expected to be the most elevated among the Group of Seven advanced economies this year and the following year.

Possible Utility Bill Measures

It is understood the government could take action to bring down utility costs, for example by slashing the current 5% level of VAT charged on energy supplies.

An additional option is to lower some of the policy costs presently included in household expenses.

Fiscal Constraints and Expert Expectations

The government will receive the next report from the official forecaster, the OBR, on the start of the week, which will clarify how much room there is for these actions.

The view from most experts is that the Chancellor will have to introduce tax rises or expenditure reductions in order to adhere to her self-imposed fiscal targets.

Previously on the same day, estimates indicated there was a £22bn deficit for the chancellor to address, which is at the lower end of forecasts.

"There's a joint responsibility between the Bank of England and the administration to further reduce some of the drivers of inflation," Reeves told the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.

Revenue Commitments and International Concerns

While much of the attention has been on likely tax increases, the chancellor said the latest figures from the OBR had not changed her vow to election pledges not to increase rates on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with increasing international and commercial tensions for the Budget revenue measures, likely to be targeted on those "with the broadest shoulders."

Global Trade Tensions

Referring to apprehensions about the UK's economic relations with China she said: "Our security interests invariably take priority."

Recent statement by China to tighten export controls on critical minerals and other resources that are essential for advanced tech production led American leader the US President to propose an further 100% import tax on imports from the Asian country, increasing the prospect of an all-out commercial conflict between the two global powers.

The American finance chief called China's move "commercial pressure" and "a international production control attempt."

Inquired about accepting the American proposal to participate in its conflict with China, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Chinese government "not to put up barriers and restrict access."

She said the action was "damaging for the world economy and creates further headwinds."

"In my view there are sectors where we should challenge Chinese policies, but there are also significant chances to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium correct."

The chancellor also confirmed she was collaborating with international partners "on our own critical minerals approach, so that we are less reliant."

Health Service Medicine Costs and Funding

Reeves also acknowledged that the cost the NHS spends on drugs could increase as a result of ongoing negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said lately that they are either pausing or abandoning projects in the United Kingdom, with several attributing the low prices they are getting.

Recently, the Science Minister said the price the NHS spends on medicines would have to rise to stop firms and drug research funding departing from the United Kingdom.

Reeves told the BBC: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been available in the UK in the manner that they are in other European countries."

"Our aim is to guarantee that patients receiving care from the NHS are can access the best life-saving drugs in the world. And so we are examining this situation, and... aiming to secure increased capital into the UK."